UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 22, 2012

 

 

Impax Laboratories, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34263   65-0403311

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

30831 Huntwood Avenue, Hayward, CA   94544
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (510) 240-6000

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

Impax Laboratories, Inc. (the “Company”) held its 2012 Annual Meeting of Stockholders on May 22, 2012. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

Proposal 1: Election of Directors

Each of the following seven nominees for director were elected to serve a term of one year and until his successor has been elected and qualified.

 

Nominee

   Votes For      Withheld Authority      Broker Non-Votes  

Leslie Z. Benet, Ph.D.

     50,364,091         1,097,753         6,467,322   

Robert L. Burr

     50,286,460         1,175,384         6,467,322   

Allen Chao, Ph.D.

     50,995,927         465,917         6,467,322   

Nigel Ten Fleming, Ph.D.

     50,357,736         1,104,108         6,467,322   

Larry Hsu, Ph.D.

     50,645,791         816,053         6,467,322   

Michael Markbreiter

     50,479,999         981,845         6,467,322   

Peter R. Terreri

     50,986,076         475,768         6,467,322   

Proposal 2: Advisory Vote on Executive Compensation

The resolution to approve, on a non-binding advisory basis, the compensation of our named executive officers was approved.

 

Votes For

  Votes Against     Abstentions     Broker Non-Votes  
50,247,687     1,185,592        28,565        6,467,322   

Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm

KPMG LLP was ratified as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012.

 

Votes For

  Votes Against     Abstentions     Broker Non-Votes  
55,932,119     1,973,721        23,326        —     


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 25, 2012   IMPAX LABORATORIES, INC.
  By:  

/s/ Arthur A. Koch, Jr.

    Name:   Arthur A. Koch, Jr.
    Title:  

Executive Vice President, Finance, and

Chief Financial Officer